N.º de artículoDLM-10627-PK
α-Muricholic acid (2,2,3,4,4-D₅, 99%)
Sinónimos(5.beta.)-3.alpha,6.beta.,7.beta.-trihydroxy-cholan-24-oic acid; 5.beta.-Cholanic
Acid-3.alpha.,6.beta.,7.beta.-triol; beta.-MCA
FórmulaC24H35D5O5
CAS Número Lebeled
CAS Número Unlabeled2393-58-0
Número CE
N.º de artículo | Package size | ||
---|---|---|---|
DLM-10627-PK | g |
Propiedades
Peso molecular413.60
Pureza98%
FormularioIndividual
ConcentraciónNeat
Aplicación(es)Clinical MS, Metabolism, Metabolomics
Temperatura de almacenamientoStore in freezer (-20°C). Protect from light.
Descripción
Product Description
α-muricholic acid (α-MCA) is an unconjugated, primary bile acid that is involved in various metabolic processes and signaling interactions. The D5 α-MCA standard can be used in investigations of bile acid synthesis/metabolism, disease linkage, and biomarker assessment.
Application(s)
Información de seguridad
Hazard Pictograms
Signal Word
Hazard Statement
Comentarios (0)
Todavía no hay comentarios.
N.º de artículoDLM-10627-PK
α-Muricholic acid (2,2,3,4,4-D₅, 99%)
This item requires an export license
when the destination country is
CN (+Hong Kong),BY, IR, IL, LB, MO, PK, RU VE.
Sinónimos(5.beta.)-3.alpha,6.beta.,7.beta.-trihydroxy-cholan-24-oic acid; 5.beta.-Cholanic
Acid-3.alpha.,6.beta.,7.beta.-triol; beta.-MCA
FórmulaC24H35D5O5
CAS Número Lebeled
CAS Número Unlabeled2393-58-0
Número CE
N.º de artículo | Package size | ||
---|---|---|---|
DLM-10627-PK | g |
Propiedades
Peso molecular413.60
Pureza98%
FormularioIndividual
ConcentraciónNeat
Aplicación(es)Clinical MS, Metabolism, Metabolomics
Temperatura de almacenamientoStore in freezer (-20°C). Protect from light.
Descripción
Product Description
α-muricholic acid (α-MCA) is an unconjugated, primary bile acid that is involved in various metabolic processes and signaling interactions. The D5 α-MCA standard can be used in investigations of bile acid synthesis/metabolism, disease linkage, and biomarker assessment.
Application(s)
Información de seguridad
Hazard Pictograms
Signal Word
Hazard Statement
Comentarios (0)
Todavía no hay comentarios.